Bone mineral density in children and young adults with beta-thalassemia major conventionally treated [2]

Pediatric Blood and Cancer

Volumn 47, Issue 1, 2006, Pages 113-114

  Christoforidis, Athanasios ^a   Hatzipantelis, Emmanouil ^a   Tsatra, Ioanna ^a   Katzos, George ^a   Athanassiou Metaxa, Miranda ^a   Kazantzidou, Eirini ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFERIPRONE; DEFEROXAMINE;

ADOLESCENT; BLOOD TRANSFUSION; BONE DENSITY; BONE MASS; CHELATION THERAPY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENDER; HUMAN; IRON CHELATION; IRON OVERLOAD; LETTER; MALE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBERTY; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SHORT STATURE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BONE DENSITY; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; OSTEOPOROSIS;

EID: 33646890262     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20802     Document Type: Letter

References (5)

1. Lal A, Fung EB, Pakbaz Z, et al. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer 2005 [e-pub ahead of print].
2. Benigno V, Bertelloni S, Baroncelli GI, et al. Effects of thassemia major on bone mineral density in late adolescence. J Pediatr Endocrinol Metab 2003;16:337-342.
3. Jensen CE, Tuck SM, Agnew JE, et al. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998;103:911-915.
4. Borgna-Pignatti C, Zurlo MG, De Stefano P. Outcome of thalassemic treated with conventional therapy. Bone Marrow Transplant 1993;12:2-4.
5. Seeman E. Growth in bone mass and size-are racial and gender differences in bone mineral density more apparent than real? J Clin Endocrinol Metab 1998;83:1414-1419.